Filing Details

Accession Number:
0001437749-23-010879
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-04-24 11:00:41
Reporting Period:
2023-04-20
Accepted Time:
2023-04-24 11:00:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
922247 Cyclo Therapeutics Inc. CYTH Biological Products, (No Disgnostic Substances) (2836) 593029743
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1499075 Jeffrey Tate 6714 Nw 16Th Street, Suite B
Gainesville FL 32163
Chief Operating Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-04-20 29,941 $0.71 62,101 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2023-04-20 29,941 $0.13 29,941 $0.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,941 2023-04-20 2030-04-20 No 4 P Direct